Your session is about to expire
← Back to Search
Mindfulness-Based Therapy for ADHD (MBAT-C Trial)
MBAT-C Trial Summary
This trial will help researchers understand if MBAT-C is a promising intervention for children with ADHD and whether a larger clinical trial is warranted.
MBAT-C Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.MBAT-C Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have been diagnosed with ADHD with symptoms like inattention, hyperactivity, or both, according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).If you are currently taking medication for ADHD, you must be willing to stop taking it for a certain period of time before starting the trial.You have been diagnosed with ADHD based on the specific symptoms outlined in the Diagnostic Statistical Manual -5 (DSM-5).I don't have conditions that make ADHD medications unsafe for me, and I'm not taking monoamine-oxidase inhibitors.I am willing to be assigned to a treatment group by chance.I am a parent of a child aged 7-13.You have certain physical conditions that may make it difficult for you to take part in the study.My child is between 7 and 13 years old.
- Group 1: Medication
- Group 2: Combined (MBAT-C + medication)
- Group 3: Mindfulness-Based ADHD Treatment for Children
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the program actively seeking out participants?
"According to clinicaltrials.gov, this medical trial is still seeking participants since its initial posting on February 1st 2021 and most recent update on June 14th 2022."
What objectives are being pursued with this clinical experiment?
"This study will primarily be assessing patient Retention over an 8-10 week period. Secondary evaluations include Attention, gauged by accuracy on a Flanker Task; ADHD Symptoms measured with the 18-item ADHD Rating Scale (ADHD-RS); and Total Problems evaluated through scores obtained from the Child Behavior Checklist (CBCL)'s 98 questions subscale."
Who has been approved to partake in this clinical investigation?
"This trial requires 45 minors between the ages of 7 and 13 that have been diagnosed with ADHD to partake. The eligibility requirements are as follows: child of any gender, commitment to the entire protocol duration, willingness for a drug wash-out period if already on medications, and acceptance in being randomized into treatment groups."
Does the research team have age restrictions, and if so, what are they?
"Participants must meet the age criteria of this trial, which requires that they are between 7 and 13 years old."
What is the total sample size of this research trial?
"Affirmative. According to clinicaltrials.gov, this medical examination is actively seeking participants; it was initially advertised on February 1st 2021 and the date of its most recent update was June 14th 2022. The trial requires 45 individuals from one specific site."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger